{
  "abstract": "Human T-lymphotropic virus type 1 (HTLV-1) is a neglected, sexually transmitted retrovirus. Around 10% of people living with HTLV-1 (PLHTLV) develop adult T cell leukaemia/lymphoma (ATLL) or severe inflammatory disease such as HTLV-1-associated myelopathy (HAM), uveitis or bronchiectasis. In addition, PLHTLV have an unexplained 1.6-fold increased adjusted mortality rate.1 HTLV-1 adversely impacts strongyloidiasis, tuberculosis and other coinfections.2 Importantly, HTLV-1 is associated with reduced quality of life, psychological distress and stigmatisation.",
  "authors": [
    {
      "affiliations": [
        "Virus Reference Department, UK Health Security Agency, London, UK",
        "National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK"
      ],
      "name": "Daniel Bradshaw"
    },
    {
      "affiliations": [
        "National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK",
        "Department of Infectious Disease, Imperial College London, London, UK"
      ],
      "name": "Graham P Taylor"
    }
  ],
  "title": "Human T-cell lymphotropic virus type 1",
  "uid": "10fc6ed2-5964-5061-98ac-2ece9e220eef"
}
